Liu Huijiao, Li Jianwei, Chen Miaolian, Su Jiahao
Department of Intensive Care Unit.
Department of Neurosurgery, Zhongshan City People's Hospital, Zhongshan, China.
Medicine (Baltimore). 2019 Aug;98(34):e16839. doi: 10.1097/MD.0000000000016839.
H7N9 infection causes acute respiratory distress syndrome with high mortality. The use of glucocorticoids in the acute phase lessened inflammatory responses. Some case reports suggested that secondary organizing pneumonia (SOP) could occur at the recovery stage of the influenza virus infection, and the treatment with glucocorticoid was effective. However, the reports of organizing pneumonia after H7N9 infection are lacking. This study reported a patient with H7N9 virus infection who presented a suspected SOP during the recovery stage.
A 68-year-old woman who was diagnosed with H7N9 viral pneumonia. After standard antiviral treatment, venous-venous extracorporeal membranous oxygenation (VV-ECMO) and other supportive treatment, the antigen in the alveolar lavage fluid turned negative, and the shadow in the lung was partially absorbed. However, the imaging manifestations were deteriorated at 3 weeks after disease onset, presented as exudation and consolidation shadow distributed under the pleura and along the bronchial vascular bundles. The oxygenation could not be improved. Repeated sputum, alveolar lavage fluid, and blood pathogen examinations showed negative results. Broad-spectrum anti-infective treatment was ineffective. However, the autoantibodies (ANA, anti-SSA/Ro60, anti-SSA/Ro52) were detected.
SOP was considered.
Glucocorticoid treatment begun at week 4 from the disease onset. The regimen was methylprednisolone at an initial dose of 40 mg twice a day for 1 week, tapering within 70 days until total withdrawal.
The oxygenation was rapidly improved after initiation of methylprednisolone. The shadow in the lung gradually resolved, and the patient was discharged after improvement of the disease condition. The clinical disease course, imaging findings, and treatment effects in the previous cases of SOP after influenza virus infection were similar to those in this case, suggesting the occurrence of SOP after H7N9 virus infection.
Organizing pneumonia might occur during the recovery stage of influenza virus infection. When the clinical symptoms do not improve and the shadow in the lung shows no obvious absorption after elimination of the H7N9 influenza virus, or the clinical symptoms are aggravated again after improvement, the probability of transforming into the organizing pneumonia should be taken into consideration.
H7N9感染可导致急性呼吸窘迫综合征,死亡率高。急性期使用糖皮质激素可减轻炎症反应。一些病例报告表明,在流感病毒感染的恢复期可能会发生继发性机化性肺炎(SOP),且糖皮质激素治疗有效。然而,缺乏H7N9感染后机化性肺炎的报道。本研究报告了1例H7N9病毒感染患者,其在恢复期出现疑似SOP。
一名68岁女性,被诊断为H7N9病毒性肺炎。经过标准抗病毒治疗、静脉-静脉体外膜肺氧合(VV-ECMO)及其他支持治疗后,肺泡灌洗液中的抗原转阴,肺部阴影部分吸收。然而,发病3周时影像学表现恶化,表现为胸膜下及沿支气管血管束分布的渗出及实变影。氧合情况无法改善。多次痰、肺泡灌洗液及血液病原体检查结果均为阴性。广谱抗感染治疗无效。但检测到自身抗体(抗核抗体、抗SSA/Ro60、抗SSA/Ro52)。
考虑为SOP。
从发病第4周开始使用糖皮质激素治疗。方案为甲泼尼龙,初始剂量为40mg,每日2次,共1周,在70天内逐渐减量直至停药。
开始使用甲泼尼龙后氧合迅速改善。肺部阴影逐渐消散,患者病情好转后出院。既往流感病毒感染后SOP病例的临床病程、影像学表现及治疗效果与本例相似,提示H7N9病毒感染后可发生SOP。
流感病毒感染恢复期可能发生机化性肺炎。当临床症状无改善且H7N9流感病毒清除后肺部阴影无明显吸收,或改善后临床症状再次加重时,应考虑转化为机化性肺炎的可能性。